Patients with increased ACE activity were shown to have a higher risk of ARDS, whereas overexpression of ACE2 has a protective effect, and ACE2-/- mice have a more severe course of ARDS that responds to recombinant ACE2 administration. The gene discussed is ACE2; the disease is acute respiratory distress syndrome.